long-term dual antithrombotic therapydiabetes treatmentslipid-lowering medicationsticagrelorezetimibemultivessel coronary artery diseaselow-dose rivaroxabanSGLT2 inhibitorsPCSK9 inhibitorsCerebrovascular disease+2 more
…, including lipid-lowering medications, diabetes treatments and long-term dual antithrombotic therapy. This was associated with a 47% lower rate of cardiovascular ev…